Role of tachykinin and bradykinin receptors and mast cells in gaseous formaldehyde-induced airway microvascular leakage in rats

European Journal of Pharmacology

Volumn 307, Issue 3, 1996, Pages 291-298

  Ito, Kazue ^a   Sakamoto, Tatsuo ^a   Hayashi, Yoshiki ^a   Morishita, Masashi ^a   Shibata, Eiji ^a   Sakai, Kiyoshi ^a   Takeuchi, Yasuhiro ^a   Torii, Shinpei ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bradykinin receptor; CP 99,994; Formaldehyde; Mast cell; Tachykinin receptor; Vascular permeability

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ RECEPTOR; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; ICATIBANT; KETOTIFEN; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; TACHYKININ RECEPTOR;

AIRWAY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; EXTRAVASATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MAST CELL; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030568703     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00285-3     Document Type: Article

References (43)

1. Abelli, L., C.A. Maggi, P. Rovero, E.D. Bianco, D. Regoli, G. Drapeau and A. Giachetti, 1991, Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptors, J. Auton. Pharmacol. 11, 267.
2. Alexandersson, R., B. Kolmodin-Hedman and G. Hedenstierna, 1982, Exposure to formaldehyde: effects on pulmonary function, Arch. Environ. Health 37, 279.
3. Ali, H., K.B.P. Leung, F.L. Pearce, N.A. Hayes and J.C. Foreman, 1986, Comparison of the histamine-releasing action of substance P on mast cells and basophils from different species and tissues, Int. Arch. Allergy Appl. Immunol. 79, 413.
4. Baluk, P., J.A. Nadel and D.M. McDonald, 1992, Substance P-immunoreactive sensory axons in the rat respiratory tract: a quantitative study of their distribution and role in neurogenic inflammation, J. Comp. Neurol. 319, 586.
5. Bardana, E.J. and A. Montanaro, 1991, Formaldehyde: an analysis of its respiratory, cutaneous, and immunologic effects, Ann. Allergy 66, 441.
6. Bertrand, C., J.A. Nadel, I. Yamawaki and P. Geppetti, 1993, Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea, J. Immunol. 151, 4902.
7. 1) receptors at sites of inflammation, Proc. Natl. Acad. Sci. USA 91, 8964.
8. Burge, P.S., M.G. Harries, W.K. Lam, I.M. O'Brien and P.A. Patchett, 1985, Occupational asthma due to formaldehyde, Thorax 40, 255.
9. Chung, K.F., D.F. Rogers, P.J. Barnes and T.W. Evans, 1990, The role of increased airway microvascular permeability and plasma exudation in asthma, Eur. Respir. J. 3, 329.
10. 1 antagonist, CP-96,345, Eur. J. Pharmacol. 203, 157.
11. Devillier, P., G. Drapeau, M. Renoux and D. Regoli, 1989, Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides, Eur. J. Pharmacol. 168, 53.
12. Dickinson, R.G. and N.W. Jacobsen, 1970, A new sensitive and specific test for the detection of aldehydes: formation of 6-mercapto-3-substituted-5-triazolo[4,3-b]-s-tetrazines, J. Chem. Soc. D Chem. Commun. 1719.
13. Dusser, D.J., E. Umeno, P.D. Graf, T. Djokic, D.B. Borson and J.A. Nadel, 1988, Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo, J. Appl. Physiol. 65, 2585.
14. Freeland, L.T., 1977, An industrial hygiene calibration manifold, Am. Ind. Hyg. Assoc. J. 38, 712.
15. Frigas, E., W.V. Filley and C.E. Reed, 1984, Bronchial challenge with formaldehyde gas: lack of bronchoconstriction in 13 patients suspected of having formaldehyde-induced asthma, Mayo Clin. Proc. 59, 295.
16. Hock, F.J., K. Wirth, U. Albus, W. Linz, H.J. Gerhards, G. Wiemer, S. Henke, G. Breipohl, W. König, J. Knolle and B.A. Schölkens, 1991, Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies, Br. J. Pharmacol. 102, 769.
17. Houlgate, P.R., K.S. Dhingra, S.J. Nash and W.H. Evans, 1989, Determination of formaldehyde and acetaldehyde in mainstream cigarette smoke by high-performance liquid chromatography, Analyst 114, 355.
18. Joos, G.F., J.C. Kips and R.A. Pauwels, 1994, In vivo characterization of the tachykinin receptors involved in the direct and indirect bronchoconstrictor effect of tachykinins in two inbred rat strains, Am. J. Respir. Crit. Care. Med. 149, 1160.
19. Kilburn, K.H., R. Warshaw, C.T. Boylen, S.J.S. Johnson, B. Seidman, R. Sinclair and T. Takaro, 1985, Pulmonary and neurobehavioral effects of formaldehyde exposure, Arch. Environ. Health 40, 254.
20. Kriebel, D., S.R. Sama and B. Cocanour, 1993, Reversible pulmonary responses to formaldehyde, Am. Rev. Respir. Dis. 148, 1509.
21. Lembeck, F., T. Griesbacher, M. Eckhardt, S. Henke, G. Breipohl and J. Knolle, 1991, New, long-acting, potent bradykinin antagonists, Br. J. Pharmacol. 102, 297.
22. Lembeck, F., J. Donnerer, M. Tsuchiya and A. Nagahisa, 1992, The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation, Br. J. Pharmacol. 105, 527.
23. Lötvall, J.O., K. Tokuyama, C.G. Löfdahl, A. Ullman, P.J. Barnes and K.F. Chung, 1991, Peptidase modulation of noncholinergic vagal bronchoconstriction and airway microvascular leakage, J. Appl. Physiol. 70, 2730.
24. Lundberg, J.M. and A. Saria, 1983, Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants, Nature 302, 251.
25. Lundberg, J.M., T. Hökfelt, C.R. Martling, A. Saria and C. Cuello, 1984, Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man, Cell Tissue Res. 235, 251.
26. Maggi, C.A., S. Giuliani, P. Santicioli, D. Regoli and A. Meli, 1987, Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors, J. Auton. Pharmacol. 7, 11.
27. Martin, U. and D. Römer, 1978, The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene, Arzneimittelforschung 28, 770.
28. Mazurek, N., I. Pecht, V.I . Teichberg and S. Blumberg, 1981, The role of the N-terminal tetrapeptide in the histamine releasing action of substance P, Neuropharmacology 20, 1025.
29. McLean, S., A. Ganong, P.A. Seymour, R.M. Snider, M.C. Desai, T. Rosen, D.K. Bryce, K.P. Longo, L.S. Reynolds, G. Robinson, A.W. Schmidt, C. Siok and J. Heym, 1993, Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor, J. Pharmacol. Exp. Ther. 267, 472.
30. Mimura, H., M. Kaneko, N. Nishiyama, S. Fukui and S. Kanno, 1976, Determination of formaldehyde by the 4-amino-3-hydrazino-5-mercapto-1,2,4-triazol method (AHMT method), J. Hyg. Chem. 22, 39.
31. Morimoto, H., M. Yamashita, A. Matsuda, H. Miyake and T. Fujii, 1992, Effects of FR 113680 and FK 224, novel tachykinin receptor antagonists, on cigarette smoke-induced rat tracheal plasma extravasation, Eur. J. Pharmacol. 224, 1.
32. Murai, M., H. Morimoto, Y. Maeda and T. Fujii, 1992, Effects of tripeptide substance P antagonist, FR113680, on airway constriction and airway edema induced by neurokinins in guinea-pigs, Eur. J. Pharmacol. 217, 23.
33. Nordman, H., H. Keskinen and M. Tuppurainen, 1985, Formaldehyde asthma - rare or overlooked? J. Allergy Clin. Immunol. 75, 91.
34. Persson, C.G.A., 1986, Role of plasma exudation in asthmatic airways, Lancet II, 1126.
35. 1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline, J. Pharmacol. Exp. Ther. 266, 270.
36. Proud, D. and A.P. Kaplan, 1988, Kinin formation: mechanisms and role in inflammatory disorders, Ann. Rev. Immunol. 6, 49.
37. Regoli, D., G. Drapeau, S. Dion and R. Couture, 1988, New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization, Trends Pharmacol. Sci. 9, 290.
38. Rogers, D.F., P. Boschetto and P.J. Barnes, 1989, Plasma exudation: correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo, J. Pharmacol. Methods 21, 309.
39. 1 receptor antagonist, against substance P-, bradykinin-and allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig, Eur. J. Pharmacol. 231, 31.
40. Samet, J.M., M.C. Marbury and J.D. Spengler, 1988, Health effects and sources of indoor air pollution, Am. Rev. Respir. Dis. 137, 221.
41. Saria, A., J.M. Lundberg, G. Skofitsch and F. Lembeck, 1983, Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge, Naunyn-Schmiedeberg's Arch. Pharmacol. 324, 212.
42. Wei, E.T. and J.G. Kiang, 1987, Inhibition of protein exudation from the trachea by corticotropin-releasing factor, Eur. J. Pharmacol. 140, 63.
43. Wirth, K., F.J. Hock, U. Albus, W. Linz, H.G. Alpermann, H. Anagostopoulos, S. Henke, G. Breipohl, W. König, J. Knolle and B.A. Schölkens, 1991, Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies, Br. J. Pharmacol. 102, 774.